Product Images Cardura XL

The text describes a graph that shows the mean plasma concentration of Doxazosin following single oral doses of 8mg Cardura XL in a fed and fasted state. The x-axis shows the time post-dose in hours, while the y-axis shows the plasma concentration in ng/mL. The graph shows two lines representing the fasted and fed states, each with varying plasma concentration levels at different time intervals.*

The text describes a graph showing the Mean Total IPSS (International Prostate Symptom Score) by week in "Study 1", with treatment and placebo groups represented by CARDURAXL and a line respectively.*

The text provides numerical data on the Mean Maximum Urinary Flow Rate (ml/sec) observed during a study divided into weeks. Figure 3 shows the mean maximum urinary flow rate (ml/sec) by Week in Study 1, comparing CARDURAXL with placebo. Therefore, this text contains data for a clinical study on urinary flow rates of individuals who received either CARDURAXL or placebo, and their mean maximum urinary flow rates were measured in different weeks.*

This text is a distribution statement indicating that Roerig, a division of Pfizer Inc, is responsible for distributing a certain product or products.*

Store the Cardura XL tablets at a temperature of 25°C (T7°F), with excursions allowed between 15-30°C (50-86°F) to maintain Controlled Room Temperature as per USP. Protect from moisture and humidity. Each tablet contains 5.1 mg of doxazosin mesylate, providing 4mg of dosage as a free base. For dosage and use instructions, please refer to the accompanying prescribing information. Cardura XL (doxazosin mesylate extended-release tablets) are distributed by Roerg Division of Przer e, in New York, NY, and made in Singapore. The tablets are only available for prescription and come in packs of 30. The LOT number and expiration date are not available.*

Store these doxazosin mesylate extended release tablets at temperatures around 25°C (77°F) or between 15-30°C (50-86°F). These tablets should be kept safe from both humidity and moisture. Each tablet has a doxazosin mesylate content of 10.2mg, which contains an 8mg free base. The accompanying prescribing information should be read for the proper dosage and use. The tablets are sold under the brand name Cardura XL and come in a package of 30 tablets. The product is distributed by Roerg, in the Division of Przer, located in New York, and it is made in Singapore. The NDC number for this product is 0049-2720-30. Therefore, it is a medication that is used to lower blood pressure.*

Store Cardura XL extended-release tablets at a temperature range of 15-30°C (50-86°F) and protect from moisture and humidity. The tablets contain 10.2mg of doxazosin mesylate, providing 8mg of doxazosin as a base. The accompanying prescribing information provides dosage and usage instructions. The tablets are distributed in a bottle containing 30 tablets by Roerg, a division of Przer, NY, NY. NDC code for Cardura XL is 0049-2080-10.*